| [1] |
中华医学会心血管病学分会肺血管病学组. 急性肺栓塞诊断与治疗中国专家共识(2015)[J]. 中华心血管病杂志, 2016, 44(3): 197-211.
|
| [2] |
Konstantinides SV, Meyer G. The 2019 ESC guidelines on the diagnosis and management of acute pulmonary embolism[J]. Eur Heart J, 2019, 40(42): 3453-3455.
|
| [3] |
Sanchez O, Trinquart L, Colombet I, et al. Prognostic value of right ventricular dysfunction in patients with haemodynamically stable pulmonary embolism: a systematic review[J]. Eur Heart J, 2008, 29(12): 1569-1577.
|
| [4] |
Souza-Costa DC, Figueiredo-Lopes L, Alves-Filho JC, et al. Protective effects of atorvastatin in rat models of acute pulmonary embolism: involvement of matrix metalloproteinase-9[J]. Crit Care Med, 2007, 35(1): 239-245.
|
| [5] |
Tanus-Santos JE, Gordo WM, Udelsmann A, et al. The hemodynamic effects of endothelin receptor antagonism duringa venous air infusion in dogs[J]. Anesth Analg, 2000, 90(1):102-106.
|
| [6] |
Battistini B. Modulation and roles of the endothelins in the pathophysiology of pulmonary embolism[J]. Can J Physiol Pharmacol, 2003, 81(6): 555-569.
|
| [7] |
Fernandez-Patron C, Stewart KG, Zhang Y, et al. Vascular matrix metalloproteinase-2-dependent cleavage of calcitonin gene-related peptide promotes vasoconstriction[J]. Circ Res, 2000, 87(8): 670-676.
|
| [8] |
Martínez A, Oh HR, Unsworth EJ, et al. Matrix metalloproteinase-2 cleavage of adrenomedullin producea vasoconstrictor out of a vasodilator[J]. Biochem J, 2004, 383(3): 413-418.
|
| [9] |
Dawar FU, Xiong Y, Khattak MNK, et al. Potential role of cyclophilin A in regulating cytokine secretion[J]. J Leukoc Biol, 2017 10, 102(4): 989-992.
|
| [10] |
Runyon MS, Gellar MA, Sanapareddy N, et al. Development and comparison of a minimally-invasive model of autologous clot pulmonary embolism in Sprague-Dawley and Copenhagen rats[J]. Thromb J, 2010, 8: 3.
|
| [11] |
Palei AC, Zaneti RA, Fortuna GM, et al. Hemodynamic benefits of matrix metalloproteinase-9 inhibition by doxycycline during experimental acute pulmonary embolism[J]. Angiology, 2005, 56(5): 611-617.
|
| [12] |
Toba M, Nagaoka T, Morio Y, et al. Involvement of Rho kinase in the pathogenesis of acute pulmonary embolism-induced polystyrene microspheres in rats[J]. Am J Physiol Lung Cell Mol Physiol, 2010, 298(3): 297-303.
|
| [13] |
Tanus-Santos JE, Theodorakis MJ. Is there a place for inhaled nitric oxide in the therapy of acute pulmonary embolism?[J]. Am J Respir Med, 2002, 1(3): 167-176.
|
| [14] |
Smulders YM. Pathophysiology and treatment of haemodynamic instability in acute pulmonary embolism: the pivotal role of pulmonary vasoconstriction[J]. Cardiovasc Res, 2000, 48(1): 23-33.
|
| [15] |
Neto-Neves EM, Dias-Junior CA, Rizzi E, et al. Metalloproteinase inhibition protects against cardiomyocyte injury during experimental acute pulmonary thromboembolism[J]. Crit Care Med, 2011, 39(2): 349-356.
|
| [16] |
Vandooren J, Van den Steen PE, Opdenakker G. Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9): the next decade[J]. Crit Rev Biochem Mol Biol, 2013, 48(3): 222-272.
|
| [17] |
Fernandez-Patron C, Zouki C, Whittal R, et al. Matrix metalloproteinases regulate neutrophil-endothelial cell adhesion through generation of endothelin-1[1-32][J]. FASEB J, 2001, 15(12): 2230-2240.
|
| [18] |
Fernandez-Patron C, Radomski MW, Davidge ST. Vascular matrix metalloproteinase-2 cleaves big endothelin-1 yielding a novel vasoconstrictor[J]. Circ Res, 1999, 85(10): 906-911.
|
| [19] |
Hao L, Du M, Lopez-Campistrous A, et al. Agonist-induced activation of matrix metalloproteinase-7 promotes vasoconstriction through the epidermal growth factor-receptor pathway[J]. Circ Res, 2004, 94(1): 68-76.
|
| [20] |
Fortuna GM, Figueiredo-Lopes L, Dias-Junior CA, et al. A role for matrix metalloproteinase-9 in the hemodynamic changes following acute pulmonary embolism[J]. Int J Cardiol, 2007, 114(1): 22-27.
|
| [21] |
Li L, Crockett E, Wang DH, et al. Gene transfer of endothelial NO synthase and manganese superoxide dismutase on arterial vascular cell adhesion molecule-1 expression and superoxide production in deoxycorticosterone acetate-salt hypertension[J]. Arterioscler Thromb Vasc Biol, 2002, 22(2): 249-255.
|
| [22] |
Garcia SRR, Minnear FL, Bizios R, et al. Role of thromboxane in the pulmonary response to pulmonary microembolization[J]. Chest, 1983, 83(5): 76S-78S.
|
| [23] |
Ghuysen A, Lambermont B, Dogné JM, et al. Effect of BM-573 [N-terbutyl-N'-[2-(4'-methylphenylamino)-5-nitro-benzenesulfonyl]urea], a dual thromboxane synthase inhibitor and thromboxane receptor antagonist, in a porcine model of acute pulmonary embolism[J]. J Pharmacol Exp Ther, 2004, 310(3): 964-972.
|
| [24] |
Seizer P, Ungern-Sternberg SN, Schonberger T, et al. Extracellular cyclophilin A activates platelets via EMMPRIN (CD147) and PI3K/Akt signaling, which promotes platelet adhesion and thrombus formation in vitro and in vivo[J]. Arterioscler Thromb Vasc Biol, 2015, 35(3): 655-663.
|